Document is current

Article History

Received: 11 May 2021

Accepted: 16 August 2021

First Online: 28 August 2021

Declarations

:

: KH, MI, TY, MH and AI are employees of Sunstar Inc. The authors participated in the preparation, analysis and interpretation of the data. HM received research support unrelated to this study from Astellas Pharma Inc., AstraZeneca K.K., Bayer, Daiichi Sankyo, Eli Lilly Japan, Kowa Pharmaceutical, Kyowa Hakko Kirin, Miki Corporation, Mitsubishi Tanabe Pharma, MSD, Nippon Boehringer Ingelheim, Nipro, Nissan Chemical Corporation, Novartis, Novo Nordisk Pharma, Ono Pharmaceutical, Sanofi, Sumitomo Dainippon Pharma, Taisho Toyama Pharmaceutical, Takeda Pharmaceutical, Sanwa Chemical, Shionogi and Teijin Pharma; and lecture fees and fees for serving on advisory boards from AstraZeneca K.K., Daiichi Sankyo, Eli Lilly Japan, Mitsubishi Tanabe Pharma, MSD, Nippon Boehringer Ingelheim, Novo Nordisk Pharma, Sanofi, Sumitomo Dainippon Pharma and Takeda Pharmaceutical. KM received grants from Astellas, AstraZeneca, Ono Pharmaceutics and Sanwa Kagaku Kenkyusho that were unrelated to this study. No other potential conflicts of interest relevant to this study are declared.

: As secondary database we used for research purposes contained anonymized data only, this article does not contain any studies with human or animal subjects performed by any of the authors. Patient informed consent was not required, because it is impossible to link the identifiers with external information.